(Q37794031)

23 August 2017

Role of 18F-DOPA PET/CT imaging in congenital hyperinsulinism (English)

1 reference

23 August 2017

0 references

Dunia Ismail

1

1 reference

PubMed ID

20878481

23 August 2017

Khalid Hussain

series ordinal

2

1 reference

23 August 2017

1 September 2010

1 reference

Reviews in Endocrine and Metabolic Disorders

23 August 2017

1 reference

23 August 2017

11

1 reference

23 August 2017

3

1 reference

23 August 2017

165-169

1 reference

https://scigraph.springernature.com/pub.10.1007/s11154-010-9145-1

23 August 2017

0 references

cites work

Unbalanced expression of 11p15 imprinted genes in focal forms of congenital hyperinsulinism: association with a reduction to homozygosity of a mutation in ABCC8 or KCNJ11

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11154-010-9145-1

Accuracy of [18F]fluorodopa positron emission tomography for diagnosing and localizing focal congenital hyperinsulinism

21 January 2018

1 reference

12 December 2020

Evaluation of [18F]fluoro-L-DOPA positron emission tomography-computed tomography for surgery in focal congenital hyperinsulinism

1 reference

12 December 2020

Persistent hyperinsulinaemic hypoglycaemia of infancy: a heterogeneous syndrome unrelated to nesidioblastosis

1 reference

12 December 2020

Mutation of the pancreatic islet inward rectifier Kir6.2 also leads to familial persistent hyperinsulinemic hypoglycemia of infancy

1 reference

12 December 2020

Proposal for a standardized protocol for 18F-DOPA-PET (PET/CT) in congenital hyperinsulinism.

1 reference

12 December 2020

Chromosome 11p15 paternal isodisomy in focal forms of neonatal hyperinsulinism

1 reference

12 December 2020

The surgical management of congenital hyperinsulinemic hypoglycemia in infancy

1 reference

12 December 2020

The diagnosis of ectopic focal hyperinsulinism of infancy with [18F]-dopa positron emission tomography.

1 reference

12 December 2020

Somatic deletion of the imprinted 11p15 region in sporadic persistent hyperinsulinemic hypoglycemia of infancy is specific of focal adenomatous hyperplasia and endorses partial pancreatectomy

1 reference

12 December 2020

[18F]-DOPA positron emission tomography for preoperative localization in congenital hyperinsulinism

1 reference

12 December 2020

Rapid genetic analysis, imaging with 18F-DOPA-PET/CT scan and laparoscopic surgery in congenital hyperinsulinism

1 reference

12 December 2020

Diagnosis and localization of focal congenital hyperinsulinism by 18F-fluorodopa PET scan.

1 reference

12 December 2020

Calcium-stimulated insulin secretion in diffuse and focal forms of congenital hyperinsulinism

1 reference

12 December 2020

Value of 18F-fluoro-L-dopa PET in the preoperative localization of focal lesions in congenital hyperinsulinism

1 reference

12 December 2020

[18F-fluoro-L-DOPA PET-CT imaging combined with genetic analysis for optimal classification and treatment in a child with severe congenital hyperinsulinism].

1 reference

12 December 2020

Hyperinsulinemic hypoglycemia of infancy (nesidioblastosis) in clinical remission: high incidence of diabetes mellitus and persistent beta-cell dysfunction at long-term follow-up

1 reference

12 December 2020

A nonsense mutation in the inward rectifier potassium channel gene, Kir6.2, is associated with familial hyperinsulinism

1 reference

12 December 2020

Focal and diffuse forms of congenital hyperinsulinism: the keys for differential diagnosis.

1 reference

12 December 2020

Clinical features of 52 neonates with hyperinsulinism.

1 reference

12 December 2020

Congenital hyperinsulinism: pancreatic [18F]fluoro-L-dihydroxyphenylalanine (DOPA) positron emission tomography and immunohistochemistry study of DOPA decarboxylase and insulin secretion

1 reference

12 December 2020

6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications

1 reference

12 December 2020

Localization of monoamine oxidase A and B in human pancreas, thyroid, and adrenal glands

1 reference

12 December 2020

The added value of [18F]fluoro-L-DOPA PET in the diagnosis of hyperinsulinism of infancy: a retrospective study involving 49 children

1 reference

12 December 2020

Dominantly inherited hyperinsulinism caused by a mutation in the sulfonylurea receptor type 1.

1 reference

12 December 2020

Molecular imaging in neuroendocrine tumors: molecular uptake mechanisms and clinical results.

1 reference

12 December 2020

Accumulation of dopamine in mouse pancreatic B-cells following injection of L-DOPA. Localization to secretory granules and inhibition of insulin secretion

1 reference

12 December 2020

Paternal mutation of the sulfonylurea receptor (SUR1) gene and maternal loss of 11p15 imprinted genes lead to persistent hyperinsulinism in focal adenomatous hyperplasia

1 reference

12 December 2020

Effects of L-dopa-induced dopamine accumulation on 45Ca2+ efflux and insulin secretion in isolated rat islets

1 reference

12 December 2020

Multiple ectopic lesions of focal islet adenomatosis identified by positron emission tomography scan in an infant with congenital hyperinsulinism.

1 reference

12 December 2020

[18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism

1 reference

12 December 2020

Noninvasive diagnosis of focal hyperinsulinism of infancy with [18F]-DOPA positron emission tomography.

1 reference

12 December 2020

Mutations in the sulfonylurea receptor gene in familial persistent hyperinsulinemic hypoglycemia of infancy

1 reference

12 December 2020

Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemia

1 reference

12 December 2020

Preoperative evaluation of infants with focal or diffuse congenital hyperinsulinism by intravenous acute insulin response tests and selective pancreatic arterial calcium stimulation

1 reference

12 December 2020

Advances in the diagnosis and management of hyperinsulinemic hypoglycemia

1 reference

12 December 2020

Acute insulin responses to calcium and tolbutamide do not differentiate focal from diffuse congenital hyperinsulinism

1 reference

12 December 2020

Medications used in the treatment of hypoglycemia due to congenital hyperinsulinism of infancy (HI).

1 reference

12 December 2020

Characterization of hyperinsulinism in infancy assessed with PET and 18F-fluoro-L-DOPA.

1 reference

12 December 2020

Demonstration of high monoaminoxidase-A levels in neuroendocrine gastroenteropancreatic tumors in vitro and in vivo-tumor visualization using positron emission tomography with 11C-harmine

1 reference

12 December 2020

Practical management of hyperinsulinism in infancy

1 reference

12 December 2020

Hyperinsulinaemic hypoglycaemia.

1 reference

12 December 2020

Clinical characteristics and biochemical mechanisms of congenital hyperinsulinism associated with dominant KATP channel mutations

1 reference

12 December 2020

10.1007/S11154-010-9145-1

Identifiers

DOI

1 reference

23 August 2017

1 reference

PubMed ID

20878481